Ultra-performance LC MS/MS method for quantification of clopidogrel active metabolite
- PMID: 20533345
- DOI: 10.1002/jssc.201000115
Ultra-performance LC MS/MS method for quantification of clopidogrel active metabolite
Abstract
A sensible ultra-performance LC-MS method was developed and validated for the quantification of clopidogrel active metabolite in human plasma, with clopidogrel D4 as internal standard. Plasma pretreatment involved a one-step protein precipitation with acetonitrile. The separation was performed by reverse-phase chromatography on a C8 column. The method was linear over the concentration range of 1-150 ng/mL. The intra- and inter-day precision values were below 17% and accuracy was from 1.7 to 7.5% at all quality control levels. The lower LOQ was 0.8 ng/mL. Sample analysis time was reduced to 5 min including sample preparation (limited to protein precipitation). The present method was successfully applied to a clopidogrel active metabolite pharmacokinetic study following oral administration to healthy volunteers.
Similar articles
-
Determination of clopidogrel in human plasma by liquid chromatography/tandem mass spectrometry: application to a clinical pharmacokinetic study.Biomed Chromatogr. 2007 Sep;21(9):883-9. doi: 10.1002/bmc.850. Biomed Chromatogr. 2007. PMID: 17472221
-
Determination of lovastatin in human plasma by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.Biomed Chromatogr. 2008 May;22(5):511-8. doi: 10.1002/bmc.962. Biomed Chromatogr. 2008. PMID: 18205133
-
Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.J Pharm Biomed Anal. 2009 Jan 15;49(1):163-7. doi: 10.1016/j.jpba.2008.10.012. Epub 2008 Oct 22. J Pharm Biomed Anal. 2009. PMID: 19046843
-
Validated HPLC method for determination of carboxylic acid metabolite of clopidogrel in human plasma and its application to a pharmacokinetic study.Biomed Chromatogr. 2006 Dec;20(12):1309-14. doi: 10.1002/bmc.697. Biomed Chromatogr. 2006. PMID: 16977589
-
Quantitative determination of clopidogrel and its metabolites in biological samples: a mini-review.J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 15;917-918:48-52. doi: 10.1016/j.jchromb.2012.12.024. Epub 2013 Jan 10. J Chromatogr B Analyt Technol Biomed Life Sci. 2013. PMID: 23369880 Review.
Cited by
-
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.Clin Pharmacol Ther. 2018 Sep;104(3):495-504. doi: 10.1002/cpt.947. Epub 2017 Dec 23. Clin Pharmacol Ther. 2018. PMID: 29171020 Free PMC article. Clinical Trial.
-
A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma.J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jan 1;880(1):132-9. doi: 10.1016/j.jchromb.2011.11.029. Epub 2011 Nov 26. J Chromatogr B Analyt Technol Biomed Life Sci. 2012. PMID: 22169056 Free PMC article.
-
Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.Clin Pharmacokinet. 2014 Feb;53(2):155-64. doi: 10.1007/s40262-013-0105-2. Clin Pharmacokinet. 2014. PMID: 24127209 Free PMC article. Clinical Trial.
-
Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers.Eur J Clin Pharmacol. 2013 Feb;69(2):179-87. doi: 10.1007/s00228-012-1329-z. Epub 2012 Jun 16. Eur J Clin Pharmacol. 2013. PMID: 22706585 Clinical Trial.
-
Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?Res Pract Thromb Haemost. 2022 Dec 13;7(1):100014. doi: 10.1016/j.rpth.2022.100014. eCollection 2023 Jan. Res Pract Thromb Haemost. 2022. PMID: 36891520 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources